Colgate-Palmolive Company CL

Colgate-Palmolive Company (Colgate) es una empresa de productos de consumo y para el hogar. La compañía opera a través de segmentos como Oral, Cuidado Personal y del Hogar, y Nutrición para Mascotas. El segmento de productos de Oral, Cuidado Personal y del Hogar se opera a través de cinco segmentos geográficos, que incluyen América del Norte, América Latina, Europa, Asia Pacífico y África/Eurasia. La compañía también está involucrada en varias categorías de productos del mercado de cuidado personal con operaciones en jabón líquido para manos, que vende bajo las marcas Palmolive, Protex y Softsoap. La compañía fabrica y comercializa una variedad de productos para el mercado del cuidado del hogar, incluyendo líquidos para lavar platos Ajax, Axion y Palmolive, y limpiadores para el hogar Ajax, Fabuloso y Murphy. La compañía, a través de su segmento Hill's Pet Nutrition (Hill's), fabrica productos de nutrición para perros y gatos.

Con 12 acciones de CL (USD 1.033,54) habrías recibido USD 25,20 en dividendos en los últimos 12 meses.

CL hizo una división de acciones (split) de 2:1 el 16 de mayo de 2013: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 30 sept

  Colgate's Innovation and Premiumization Drive: Can Momentum Persist?

  Colgate-Palmolive is strengthening its market position through innovation, premiumization of oral-care products, and expansion in emerging markets. The company is introducing differentiated products targeting whitening, sensitivity, and gum health, while leveraging its strong global brands. However, sustaining momentum depends on balancing pricing with volume, successful product launches, and cost management. Colgate trades at a premium valuation (21.5X forward P/E vs. industry 18.4X) with modest EPS growth projected at 4.9% for 2026 and 5.2% for 2027.

  

• Zacks Investment Research 29 sept

  McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

  McCormick & Company is expected to report Q3 2026 revenues rising 14.7% to ~$2 billion, but earnings may fall 11.8% to 75 cents per share. Growth drivers include the Flavor Solutions segment, pricing actions, and CCI productivity savings, while headwinds include consumer price sensitivity, competitive pressures, and inflationary expenses. The company carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -1.97%, suggesting limited likelihood of an earnings beat.

  

• The Motley Fool 23 sept

  This Dividend King Was Removed From the S&P 100. Here's Why It's a Great Buy for Long-Term Investors Anyway.

  Colgate-Palmolive was removed from the S&P 100 index due to its $69 billion market cap being eclipsed by faster-growing AI-driven stocks, but the company remains a solid long-term investment. With 63 consecutive years of dividend increases, a 347% total return over 20 years, and expected 17% EPS CAGR through 2028, the stock offers stability and growth potential despite being a slower-growth consumer staples company.

  

• Zacks Investment Research 21 sept

  Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?

  Procter & Gamble faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as it attempts to balance pricing strategies with volume growth in a challenging consumer environment. While pricing contributed to 1% organic sales growth in fiscal 2026, volume remained flat in Q4. PG plans to shift toward more balanced growth through innovation, promotions, and disciplined pricing rather than relying solely on price increases, which risk consumer trade-downs and reduced purchase frequency.

  

• Zacks Investment Research 16 sept

  Can Colgate Revive North America Growth in the Second Half?

  Colgate-Palmolive (CL) is addressing weak North America performance in Q2 2026 caused by soft category trends, competitive pressure, and retailer destocking. The company plans to boost premium toothpaste products, expand Fabuloso, increase advertising spending, and implement targeted pricing to drive market-share recovery in the second half of 2026. Management expects sequential improvement but cautioned recovery will be uneven and dependent on consumer demand health.